Medinol Injection (Pridinol Mesylate)

Adult dosage

Adults: Administer 2㎎ of pridinol mesylate once daily by intramuscular or intravenous injection. The dose may be adjusted according to age and symptoms.

When opening the injection container, be careful to avoid glass particles entering, as this may occur, so the container should be cut carefully. Particularly caution is needed when using it for children or the elderly. This medication should not be used in certain patients. For example, those who are allergic to this medication, patients with glaucoma, individuals with urinary difficulties due to prostate enlargement, persons with severe heart disease, intestinal obstruction, colonic dilatation, acute pulmonary edema, rapid heart rate, severe atherosclerosis, and patients with narrowed gastrointestinal tracts should not receive this medication. Patients with liver or kidney dysfunction should use this medication with increased caution. Using this medication can cause allergic reactions manifesting as skin rashes or hives; in severe cases, symptoms similar to shock may occur, thus the medication should be discontinued immediately if such symptoms appear. Additionally, neurological symptoms such as dizziness, drowsiness, hallucinations, and lethargy may occur, and in these situations, the dosage should be reduced or discontinued. Muscle relaxation or weakness may rarely occur, and dry mouth, nausea, and vomiting can also arise. Skin rashes or erythema, disturbances in visual accommodation, or exacerbation of glaucoma may also appear. Drowsiness or decreased concentration may occur while taking this medication, so dangerous activities such as driving or operating machinery should be avoided. This medication may have an enhanced effect when used with other central nervous system depressants or certain medications, so consultation with a physician is essential, and dosage adjustments must be made as necessary. Women who are pregnant or may become pregnant may find the use of this medication unsafe, thus it should only be used when the benefits outweigh the risks and breastfeeding women should avoid its use as it can be transmitted through breast milk. Safety for children has not been sufficiently established, so it should only be used when absolutely necessary. The elderly may have decreased physical function, hence caution should be exercised including reducing the dose of this medication. This medication is used in injection form only when oral administration is not possible and it is preferable to slowly inject after diluting with saline or dextrose solution during intravenous administration. The injection should be administered with the patient lying on their side.

• Rash
• urticaria
• anaphylactic symptoms
• shock-like symptoms
• dizziness
• staggering
• fainting
• drowsiness
• anxiety
• hallucinations

This medication should be stored in a tightly closed container that can block light and in a dry and cool place.

Appearance

A brown ampoule containing a colorless and transparent liquid.

Package unit

Domestic use: 1mL/ampoule X 50, Export: 1mL/ampoule X 50